Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1186/s13019-020-01299-5 http://scihub22266oqcxt.onion/10.1186/s13019-020-01299-5 32907637!7480628!32907637     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32907637&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       J+Cardiothorac+Surg 2020 ; 15 (1): 239 Nephropedia Template TP {{tp|p=32907637|t=2020. COVID-19: an update and cardiac involvement |pdf=|usr=}}{{32907637}} gab.com Text COVID-19: an update and cardiac involvement JO: J Cardiothorac Surg http://www.kidney.de/pget.php?&tw=1&pmid=32907637 #FOAvip Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects host cells through angiotensin converting enzyme 2 receptors, leading to coronavirus disease (COVID-19)-related pneumonia, and also causing acute cardiac injury and chronic damage to the cardiovascular system. The purpose of this review is primarily reviewing the COVID-19 disease, including pathogen, clinical features, diagnosis, and treatment with particular attention to cardiovascular involvement based on the current evidence. COVID-19 remains a threat to global public health. The associated extra-pulmonary manifestations and their prolonged consequences are frequently overlooked. Pre-existing cardiovascular disease or acute cardiac complications may contribute to adverse early clinical outcome. At the moment, there is no specific treatment for COVID-19, but multiple randomized controlled trials (RCT) are being conducted. New supportive therapies are being evaluated with promising results. Twit Text FOAVip COVID-19: an update and cardiac involvement ????J Cardiothorac Surg http://www.kidney.de/pget.php?&tw=1&pmid=32907637 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32907637 #FOAvip English Wikipedia <ref>{{Cite pmid|32907637}}</ref> COVID-19: an update and cardiac involvement #MMPMID32907637 Alwaqfi NR; Ibrahim KS J Cardiothorac Surg 2020[Sep]; 15 (1): 239 PMID32907637show ga Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects host cells through angiotensin converting enzyme 2 receptors, leading to coronavirus disease (COVID-19)-related pneumonia, and also causing acute cardiac injury and chronic damage to the cardiovascular system. The purpose of this review is primarily reviewing the COVID-19 disease, including pathogen, clinical features, diagnosis, and treatment with particular attention to cardiovascular involvement based on the current evidence. COVID-19 remains a threat to global public health. The associated extra-pulmonary manifestations and their prolonged consequences are frequently overlooked. Pre-existing cardiovascular disease or acute cardiac complications may contribute to adverse early clinical outcome. At the moment, there is no specific treatment for COVID-19, but multiple randomized controlled trials (RCT) are being conducted. New supportive therapies are being evaluated with promising results. |*Betacoronavirus[MESH] |COVID-19[MESH] |Cardiovascular Diseases/diagnosis/therapy/*virology[MESH] |Coronavirus Infections/diagnosis/*physiopathology/therapy[MESH] |Global Health[MESH] |Humans[MESH] |Pandemics[MESH] |Pneumonia, Viral/diagnosis/*physiopathology/therapy[MESH]COVID-19: an update and cardiac involvement (epmc).pdf DeepDyve Pubget Overpricing